Literature DB >> 10399950

Growth-factor-dependent migration of human lung-cancer cells.

C G Bredin1, Z Liu, D Hauzenberger, J Klominek.   

Abstract

Human lung tumors express different types of growth-factor receptors and corresponding ligands that might modulate several biological functions such as proliferation, differentiation, adhesion, and chemotaxis. In the present study, we have investigated the expression of different growth-factor receptors and their ligands in 5 established human lung-cancer cell lines. Using RT-PCR, we found that IGF-II/mannose-6-phosphate (M6P), c-met, EGF and c-kit receptors are expressed in 5/5 human lung-cancer cell lines. In order to investigate the biological function of these receptors, we performed Boyden-chamber assays using various growth factors as chemo-attractants. Human non-small-cell-lung-cancer cells (non-SCLC) migrated to recombinant human (rh)IGF I and IGF II at concentrations ranging from 1 to 1000 ng/ml, to HGF at 10 to 100 ng/ml, to EGF at 1 to 100 ng/ml and SCF at 1 to 50 ng/ml. In addition, we performed Boyden-chamber assays using U-1810-, U-1752- and Wart-derived serum-free conditioned medium as chemo-attractants. Serum-free conditioned medium stimulated migration of producer cells in a dose-dependent manner. The autocrine motility stimulating effect of U-1810-derived serum-free conditioned medium could be inhibited by 50% in the presence of neutralizing ahIGF-II antibodies in the assay, suggesting a possible autocrine motility loop in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399950     DOI: 10.1002/(sici)1097-0215(19990730)82:3<338::aid-ijc6>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Authors:  Amy L McDoniels-Silvers; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

2.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

Authors:  Jasti S Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A Joseph; Sajani S Lakka
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

3.  Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.

Authors:  Y Min; Y Adachi; H Yamamoto; A Imsumran; Y Arimura; T Endo; Y Hinoda; C-T Lee; S Nadaf; D P Carbone; K Imai
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

Authors:  Q Xie; K D Liu; M Y Hu; K Zhou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

5.  NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.

Authors:  Jie Shen; Lijun Xu; Taofeek K Owonikoko; Shi-Yong Sun; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Lett       Date:  2011-12-13       Impact factor: 8.679

6.  Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.

Authors:  Z Liu; J Klominek
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

7.  Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.

Authors:  M Sasaki; T Ito; M Kashima; S Fukui; N Izumiyama; A Watanabe; M Sano; Y Fujiwara; M Miura
Journal:  Mediators Inflamm       Date:  2001-10       Impact factor: 4.711

8.  Hepatocyte growth factor-loaded biomaterials for mesenchymal stem cell recruitment.

Authors:  Julia van de Kamp; Willi Jahnen-Dechent; Bjoern Rath; Ruth Knuechel; Sabine Neuss
Journal:  Stem Cells Int       Date:  2013-06-18       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.